Senior Director, Medical Affairs Strategy & Launch--Hematology
Sumitomo Pharma America (SMPA) · United States · US
Medical Affairs
Remote
physician
Pharmacist
Dentist
Demand72
Career growth76
Healthcare fit68
Remote potential35
Salary band
USD 247k – 309k
5-year outlook
Senior Medical Affairs roles in hematology-oncology are typically competitively compensated and can grow into VP/Medical Affairs leadership, but compensation depends on location, company size, and prior launch experience; no salary figure is stated.
Clinical license
Not required
Applicant reach
narrow
Seniority
senior
Employment type
full-time
Date found
2026-10-23
Intelligence details
Flexible work details
- Engagement type
- Permanent
- Hours
- Full-time
- Eligible countries
- United States
- License jurisdiction
- US
- Profession fit
- physician, Pharmacist, Dentist
- Rate period
- Annual
Listing via Himalayas.
Eligibility, licensing, and location restrictions can change. Always confirm details on the source posting before applying.
Why this is worth applying to
Worth considering only if you have strong hematology-oncology clinical/scientific depth plus prior pharma Medical Affairs or launch experience; most clinicians without that background will be underqualified.
Who should apply
Hematology-oncology physicians, PharmDs, or PhD-trained scientists with pharmaceutical Medical Affairs, launch readiness, KOL engagement, and evidence-generation experience; clinical experts with strong publications and industry exposure.
CV angle
Frame real hematology-oncology clinical experience as scientific leadership: disease-state expertise, KOL/investigator relationships, advisory board participation, publications, evidence gaps, and cross-functional collaboration; quantify launch or program contributions where genuine.
Skills to highlight
- Medical Affairs strategy
- Hematology-oncology scientific expertise
- Launch readiness
- KOL engagement
- Evidence generation
- Cross-functional collaboration
- Publication planning
- HEOR/RWE
Role summary
Senior pharmaceutical Medical Affairs role leading medical strategy and launch readiness for hematologic malignancy assets, including KOL engagement, evidence generation, advisory boards, publications, and cross-functional launch planning.
We publish our own intelligence summary, never the full job description. Always confirm details with the employer when you apply.